UniProt ID | AT8A2_HUMAN | |
---|---|---|
UniProt AC | Q9NTI2 | |
Protein Name | Phospholipid-transporting ATPase IB | |
Gene Name | ATP8A2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1148 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . Golgi apparatus . Endosome. Cell projection, cilium, photoreceptor outer segment. Cell membrane . Localizes to the Golgi and endosomes in photoreceptor cells. Localizes to disk membranes of rod photoreceptor o |
|
Protein Description | Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules. Reconstituted to liposomes, the ATP8A2:TMEM30A flippase complex predomiminantly transports phosphatidylserine (PS) and to a lesser extent phosphatidylethanolamine (PE). Proposed to function in the generation and maintenance of phospholipid asymmetry in photoreceptor disk membranes and neuronal axon membranes. May be involved in vesicle trafficking in neuronal cells. Involved in regulation of neurite outgrowth; acting in synergy with TMEM30A. Required for normal visual and auditory function; involved in photoreceptor and inner ear spiral ganglion cell survival.. | |
Protein Sequence | MSRATSVGDQLEAPARTIYLNQPHLNKFRDNQISTAKYSVLTFLPRFLYEQIRRAANAFFLFIALLQQIPDVSPTGRYTTLVPLIIILTIAGIKEIVEDFKRHKADNAVNKKKTIVLRNGMWHTIMWKEVAVGDIVKVVNGQYLPADVVLLSSSEPQAMCYVETANLDGETNLKIRQGLSHTADMQTREVLMKLSGTIECEGPNRHLYDFTGNLNLDGKSLVALGPDQILLRGTQLRNTQWVFGIVVYTGHDTKLMQNSTKAPLKRSNVEKVTNVQILVLFGILLVMALVSSAGALYWNRSHGEKNWYIKKMDTTSDNFGYNLLTFIILYNNLIPISLLVTLEVVKYTQALFINWDTDMYYIGNDTPAMARTSNLNEELGQVKYLFSDKTGTLTCNIMNFKKCSIAGVTYGHFPELAREPSSDDFCRMPPPCSDSCDFDDPRLLKNIEDRHPTAPCIQEFLTLLAVCHTVVPEKDGDNIIYQASSPDEAALVKGAKKLGFVFTARTPFSVIIEAMGQEQTFGILNVLEFSSDRKRMSVIVRTPSGRLRLYCKGADNVIFERLSKDSKYMEETLCHLEYFATEGLRTLCVAYADLSENEYEEWLKVYQEASTILKDRAQRLEECYEIIEKNLLLLGATAIEDRLQAGVPETIATLLKAEIKIWVLTGDKQETAINIGYSCRLVSQNMALILLKEDSLDATRAAITQHCTDLGNLLGKENDVALIIDGHTLKYALSFEVRRSFLDLALSCKAVICCRVSPLQKSEIVDVVKKRVKAITLAIGDGANDVGMIQTAHVGVGISGNEGMQATNNSDYAIAQFSYLEKLLLVHGAWSYNRVTKCILYCFYKNVVLYIIELWFAFVNGFSGQILFERWCIGLYNVIFTALPPFTLGIFERSCTQESMLRFPQLYKITQNGEGFNTKVFWGHCINALVHSLILFWFPMKALEHDTVLTSGHATDYLFVGNIVYTYVVVTVCLKAGLETTAWTKFSHLAVWGSMLTWLVFFGIYSTIWPTIPIAPDMRGQATMVLSSAHFWLGLFLVPTACLIEDVAWRAAKHTCKKTLLEEVQELETKSRVLGKAVLRDSNGKRLNERDRLIKRLGRKTPPTLFRGSSLQQGVPHGYAFSQEEHGAVSQEEVIRAYDTTKKKSRKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRATSVGD ------CCCCCCHHH | 41.76 | 20363803 | |
5 | Phosphorylation | ---MSRATSVGDQLE ---CCCCCCHHHHCC | 23.88 | 20363803 | |
6 | Phosphorylation | --MSRATSVGDQLEA --CCCCCCHHHHCCC | 24.10 | 20363803 | |
23 | Phosphorylation | RTIYLNQPHLNKFRD EEEEECCHHHHHCCC | 32.62 | 24719451 | |
24 | Phosphorylation | TIYLNQPHLNKFRDN EEEECCHHHHHCCCC | 32.07 | 24719451 | |
30 | Phosphorylation | PHLNKFRDNQISTAK HHHHHCCCCCCCHHH | 55.29 | 24719451 | |
34 | Phosphorylation | KFRDNQISTAKYSVL HCCCCCCCHHHHHHH | 16.73 | - | |
45 | Phosphorylation | YSVLTFLPRFLYEQI HHHHHHHHHHHHHHH | 22.30 | - | |
46 | Phosphorylation | SVLTFLPRFLYEQIR HHHHHHHHHHHHHHH | 36.03 | 19664994 | |
112 | Acetylation | ADNAVNKKKTIVLRN CCCCCCCCCEEEEEC | 50.36 | 20167786 | |
128 | Acetylation | MWHTIMWKEVAVGDI CEEEEEEEEEECCCE | 25.57 | 20167786 | |
239 | Phosphorylation | RGTQLRNTQWVFGIV ECCCCCCCCEEEEEE | 19.85 | - | |
248 | Phosphorylation | WVFGIVVYTGHDTKL EEEEEEEEECCCHHH | 8.98 | - | |
249 | Phosphorylation | VFGIVVYTGHDTKLM EEEEEEEECCCHHHC | 19.21 | - | |
253 | Phosphorylation | VVYTGHDTKLMQNST EEEECCCHHHCCCCC | 22.02 | - | |
259 | Phosphorylation | DTKLMQNSTKAPLKR CHHHCCCCCCCCCCC | 17.88 | - | |
260 | Phosphorylation | TKLMQNSTKAPLKRS HHHCCCCCCCCCCCC | 38.48 | - | |
267 | Phosphorylation | TKAPLKRSNVEKVTN CCCCCCCCCCCCCHH | 43.57 | - | |
372 | Phosphorylation | DTPAMARTSNLNEEL CCHHHHHCCCCCHHH | 16.66 | - | |
373 | Phosphorylation | TPAMARTSNLNEELG CHHHHHCCCCCHHHC | 33.49 | 23898821 | |
383 | Ubiquitination | NEELGQVKYLFSDKT CHHHCCCEEEEECCC | 28.48 | - | |
384 | Phosphorylation | EELGQVKYLFSDKTG HHHCCCEEEEECCCC | 17.70 | 23898821 | |
387 | Phosphorylation | GQVKYLFSDKTGTLT CCCEEEEECCCCEEE | 35.29 | 23898821 | |
390 | Phosphorylation | KYLFSDKTGTLTCNI EEEEECCCCEEEEEE | 40.15 | 22210691 | |
404 | Phosphorylation | IMNFKKCSIAGVTYG EECCCCCEEEEEEEC | 25.09 | - | |
409 | Phosphorylation | KCSIAGVTYGHFPEL CCEEEEEEECCCHHH | 23.91 | - | |
410 | Phosphorylation | CSIAGVTYGHFPELA CEEEEEEECCCHHHC | 13.24 | - | |
421 | Phosphorylation | PELAREPSSDDFCRM HHHCCCCCCCCCCCC | 41.46 | 29691806 | |
422 | Phosphorylation | ELAREPSSDDFCRMP HHCCCCCCCCCCCCC | 52.49 | 29691806 | |
453 | Phosphorylation | NIEDRHPTAPCIQEF CCHHHCCCCHHHHHH | 36.79 | - | |
506 | Phosphorylation | GFVFTARTPFSVIIE CEEEEECCCCCHHHH | 26.65 | - | |
509 | Phosphorylation | FTARTPFSVIIEAMG EEECCCCCHHHHHCC | 17.38 | - | |
563 | Phosphorylation | NVIFERLSKDSKYME CEEEEECCCCCHHHH | 40.41 | 20068231 | |
566 | Phosphorylation | FERLSKDSKYMEETL EEECCCCCHHHHHHH | 29.44 | 20068231 | |
603 | Phosphorylation | ENEYEEWLKVYQEAS CCHHHHHHHHHHHHH | 2.80 | 20068231 | |
606 | Phosphorylation | YEEWLKVYQEASTIL HHHHHHHHHHHHHHH | 10.07 | 20068231 | |
650 | Phosphorylation | LQAGVPETIATLLKA HHCCCCHHHHHHHHH | 15.16 | - | |
695 | Phosphorylation | LILLKEDSLDATRAA EEEEECCCCHHHHHH | 29.28 | - | |
762 | Phosphorylation | RVSPLQKSEIVDVVK CCCCCCCCHHHHHHH | 21.42 | 27794612 | |
1005 | Phosphorylation | WLVFFGIYSTIWPTI HHHHHHHHHHHCCCC | 10.51 | 24248375 | |
1006 | Phosphorylation | LVFFGIYSTIWPTIP HHHHHHHHHHCCCCC | 16.11 | 24248375 | |
1101 | Phosphorylation | IKRLGRKTPPTLFRG HHHHCCCCCCCCCCC | 32.89 | 29691806 | |
1104 | Phosphorylation | LGRKTPPTLFRGSSL HCCCCCCCCCCCCCC | 39.47 | 29691806 | |
1109 | Phosphorylation | PPTLFRGSSLQQGVP CCCCCCCCCCCCCCC | 24.50 | 22210691 | |
1110 | Phosphorylation | PTLFRGSSLQQGVPH CCCCCCCCCCCCCCC | 32.78 | 22210691 | |
1119 | Phosphorylation | QQGVPHGYAFSQEEH CCCCCCCCCCCHHHC | 11.05 | 22210691 | |
1130 | Phosphorylation | QEEHGAVSQEEVIRA HHHCCCCCHHHHHHH | 31.19 | 22210691 | |
1138 | Phosphorylation | QEEVIRAYDTTKKKS HHHHHHHHHCCCCCC | 12.18 | 20860994 | |
1141 | Phosphorylation | VIRAYDTTKKKSRKK HHHHHHCCCCCCCCC | 37.66 | 20860994 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AT8A2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AT8A2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AT8A2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UIMC1_HUMAN | UIMC1 | physical | 17621610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...